PapersPMID:42227307
Vitamin B12 supplementation for growth, development, and cognition in children.
What moved
1 findingHow to read these marks →“Vitamin B12 supplementation in children reduces vitamin B12 deficiency (absolute risk difference (ARD) 56 fewer per 1000, 95% CI 68 fewer to 24 fewer; 1.8% versus 7.6%; risk ratio (RR) 0.27, 95% CI 0.11 to 0.69; 3 trials, 642 children; high-certainty evidence), and probably increases total vitamin B12 concentrations (MD 68.53 pmol/L, 95% CI 41.83 to 95.23; 7 trials, 705 children; moderate-certainty evidence), compared to placebo, with an average increase of 68.5 pmol/L.”
- Study
- meta-analysis
- Participants
- 705
- Effect
- 68.53 mean difference, 95% CI 41.83 to 95.23
- Population
- Children under 12 years in randomised trials of oral vitamin B12 alone versus placebo, pooled
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Children less than 12 years of age
- Participants
- 4,083
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 13
- Declined
- this platform holds no node for the endpoint